Novo Nordisk - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

All Categories ... Pharma Companies » ... Novo Nordisk

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN5401; Drug: insulin detemir; Drug: insulin aspart; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects

Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9925 (oral); Drug: NN9925 (i.v.); Drug: placebo; Drug: NN9925 (oral); Drug: placebo
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

Condition: Atrophic Vaginitis
Interventions: Drug: intravaginal estradiol; Drug: intravaginal estradiol
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

Conditions: Congenital FXIII Deficiency; Healthy
Interventions: Drug: recombinant factor XIII; Drug: recombinant factor XIII
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

Condition: Diabetes Mellitus, Type 2
Intervention: Drug: repaglinide
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Eviana® for 12 Months

Condition: Hormone Replacement Therapy, Post-Menopausal
Intervention: Drug: 0.5 mg estradiol and 0.1mg norethisterone acetate
Sponsor: Novo Nordisk
Not yet recruiting - verified February 2010
Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: NN1250
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment.

Condition: Diabetes Type 2
Interventions: Drug: Insulin-Levemir; Drug: Exenatide-Bayetta; Drug: Insulin-Levemir and Exenatide-Bayetta; Device: SenseWear Pro3® armband; Device: DexCom CGM
Sponsors: Novo Nordisk; BodyMedia
Recruiting - verified June 2009
Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Effect of Ketllebell Training

Condition: Musculoskeletal Disorders
Interventions: Behavioral: Ketllebell training; Behavioral: Control
Sponsor: National Research Centre for the Working Environment, Denmark
Not yet recruiting - verified February 2010

Novo Nordisk - Database of Clinical Trials by Pharmaceutical Companies - Clinical Trials

Novo Nordisk - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials